CME GROUP INC. Quarterly Income Tax Expense (Benefit) in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Cme Group Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2010 to Q3 2024.
  • Cme Group Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $264M, a 17.8% increase year-over-year.
  • Cme Group Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $985M, a 6.44% increase year-over-year.
  • Cme Group Inc. annual Income Tax Expense (Benefit) for 2023 was $927M, a 16% increase from 2022.
  • Cme Group Inc. annual Income Tax Expense (Benefit) for 2022 was $799M, a 8.5% increase from 2021.
  • Cme Group Inc. annual Income Tax Expense (Benefit) for 2021 was $737M, a 19.7% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $985M $264M +$40M +17.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $945M $271M +$32.5M +13.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $913M $258M -$14.9M -5.46% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $927M $191M +$2M +1.06% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $925M $224M +$23.7M +11.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 $902M $239M +$34.6M +16.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 $867M $273M +$67.8M +33% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 $799M $189M +$15.3M +8.79% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $784M $200M +$30.8M +18.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $753M $204M -$11.3M -5.24% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $765M $205M +$27.8M +15.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $737M $174M +$63.9M +58% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $673M $170M +$44.6M +35.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $628M $216M +$57.5M +36.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $571M $178M -$45M -20.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $616M $110M -$44.9M -28.9% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 $661M $125M +$38.1M +43.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $623M $158M -$29.5M -15.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $652M $223M +$78.2M +54.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $574M $155M -$128M -45.3% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 $702M $86.9M -$63.1M -42.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $765M $188M -$3.2M -1.68% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $769M $144M -$45.6M -24% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $814M $284M +$2.65B Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 -$1.83B $150M -$149M -49.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 -$1.69B $191M -$30.8M -13.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 -$1.65B $190M -$117M -38.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 -$1.54B -$2.36B -$2.59B -1171% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-28
Q3 2017 $1.05B $299M +$223M +293% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-02
Q2 2017 $826M $222M -$24.5M -9.96% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-01
Q1 2017 $850M $307M +$96.5M +45.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
Q4 2016 $754M $221M +$44M +24.9% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $710M $76M -$80.5M -51.4% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 $790M $246M +$62.9M +34.4% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 $727M $211M +$17.3M +8.95% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $710M $177M +$9.5M +5.68% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-01
Q3 2015 $700M $157M +$17.4M +12.5% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 $683M $183M +$24.8M +15.7% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 $658M $193M +$13.6M +7.56% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-04
Q4 2014 $645M $167M +$53.4M +46.9% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-27
Q3 2014 $591M $139M -$23.5M -14.5% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $615M $158M -$37.9M -19.3% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 $653M $180M +$29.6M +19.7% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q4 2013 $623M $114M -$71.5M -38.6% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-26
Q3 2013 $694M $163M -$14.3M -8.08% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-03
Q2 2013 $709M $196M -$61.1M -23.7% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-04
Q1 2013 $770M $150M -$16.9M -10.1% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-07
Q4 2012 $787M $185M +$562M Oct 1, 2012 Dec 31, 2012 10-K 2015-02-26
Q3 2012 $224M $177M -$54M -23.4% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-08
Q2 2012 $278M $257M +$43.6M +20.4% Apr 1, 2012 Jun 30, 2012 10-Q/A 2013-08-09
Q1 2012 $235M $167M +$113M +207% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q4 2011 $122M -$377M -$608M -263% Oct 1, 2011 Dec 31, 2011 10-K 2014-03-03
Q3 2011 $730M $231M +$59.5M +34.7% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 $670M $214M +$4.8M +2.3% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-08
Q1 2011 $666M $54.5M -$104M -65.7% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-08
Q4 2010 $770M $231M Oct 1, 2010 Dec 31, 2010 10-K 2013-03-01
Q3 2010 $171M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-09
Q2 2010 $209M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
Q1 2010 $159M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.